Scleroligation for Eradication of Gastroesophageal Varices.

Sherief Abd-Elsalam90 enrolled

Overview

Gastric varices occur in 5-33% of patients with portal hypertension. Concomitant gastro esophageal varices are the most common type. Both endoscopic sclerotherapy and band ligation are very effective in controlling acute esophageal varices bleeding and preventing rebleeding.

Evaluation of a new scleroligation technique for management of bleeding gastro-esophageal varices regarding efficacy, complications, variceal recurrence, and survival.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Gastroesophageal Varices

Interventions

SclerotherapyPROCEDURE

Injection of varices

Band ligationPROCEDURE

endoscopic banding of varices

ScleroligationPROCEDURE

intra variceal endoscopic sclerotherapy combined with band ligation.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * cirrhotic patients presenting with an acute or recent episode of gastro-esophageal variceal bleeding. Exclusion Criteria: * Patients were excluded if they had malignancy of any origin. * Any terminal illness, such as heart failure, uremia, or chronic pulmonary diseases. * Other potential causes of GIT bleeding. * Patients with previous endoscopic or surgical intervention for varices were also excluded.

Locations (1)

Tropical medicine dept.-Tanta university hospital

Tanta, Egypt

RECRUITING

Outcomes

Primary Outcomes

Number of sessions to complete variceal obliteration

Time frame: 1 year

Central Contacts

Sherief M. Abd-Elsalam, Consultant

CONTACT

00201095159522 sherif_tropical@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.